Intravenous immunotherapy in the treatment of multiple sclerosis
Intravenous immunoglobulin is the drug of choice in the treatment of many autoimmune diseases. The paper presents a review of the literature with an analysis of the results of clinical trials of intravenous immunotherapy for multiple sclerosis. We have reflected our own experience in the use of this therapy in multiple sclerosis in children.